Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade

Lu, Kwok-Tung PhD; Cheng, Nai-Chi BS; Wu, Chang-Yen BS; Yang, Yi-Ling PhD

doi: 10.1097/CCM.0B013E31816590C4
Neurologic Critical Care

Objective: Brain edema is one of the characteristic features of patients with severe traumatic brain injury. The aim of this study was to examine the effects of Na+-K+-2Cl co-transporter on traumatic brain injury-induced brain edema and neuron damage and to elucidate the relationship between Na+-K+-2Cl co-transporter and mitogen-activated protein kinase (MAPK) cascade.

Design: Laboratory investigation.

Setting: University research laboratory.

Subjects: Male Wistar rats weighing 350–400 g.

Interventions: Anesthetized animals were subjected to a weight-drop device (450-g weight, 1.8-m height) to induce traumatic brain injury.

Measurements and Main Results: The expression of Na+-K+-2Cl co-transporter and phosphorylation of MAPK cascade were determined by Western blot test. We also analyzed the degree of brain edema and neuronal damage in this study. We found that the messenger RNA and protein of Na+-K+-2Cl co-transporter were up-regulated mainly in hippocampus neurons from 2 to 24 hrs after traumatic brain injury. After traumatic brain injury, animals displayed severe brain edema and neuron damage. The phosphorylation of extracellular signal-regulated kinase, MAPK kinase, and Raf also was significantly elevated after traumatic brain injury. Bumetanide (15.2 mg/kg), a specific Na+-K+-2Cl co-transporter inhibitor, significantly attenuated the neuronal damage and brain edema after traumatic brain injury by decreasing the phosphorylation of Raf/MEK/ERK cascade proteins.

Conclusions: The present study suggests that Na+-K+-2Cl co-transporter plays an important role in TBI-induced brain edema and neuronal damage via activation of MAPK cascade.

From the Department of Life Science, National Taiwan Normal University, Taipei, Taiwan (KTL); and the Institute of Biotechnology, National Chia-Yi University, Chia-Yi, Taiwan (NCC, CYW, YLY).

Supported, in part, by grants NSC 93-2320-B-415-001 and 94-2320-B-005-025 from the National Science Council, Taiwan.

The authors have not disclosed any potential conflicts of interest.

For information regarding this article, E-mail:

© 2008 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins